Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-α are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood...
Saved in:
Published in | Clinical and experimental immunology Vol. 152; no. 3; pp. 482 - 487 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Oxford, UK : Blackwell Publishing Ltd
01.06.2008
Blackwell Publishing Ltd Blackwell Blackwell Science Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-α are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription-polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN-α and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN-α and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-α mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-α mRNA in PBMCs may also contribute to the pathogenesis of human lupus. |
---|---|
AbstractList | Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-alpha are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription-polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN-alpha and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN-alpha and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-alpha mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-alpha mRNA in PBMCs may also contribute to the pathogenesis of human lupus.Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-alpha are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription-polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN-alpha and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN-alpha and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-alpha mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-alpha mRNA in PBMCs may also contribute to the pathogenesis of human lupus. Summary Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll‐like receptors (TLR‐7 and TLR‐9) and interferon (IFN)‐α are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR‐9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real‐time reverse transcription–polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN‐α and LY6E (a type I IFN‐inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN‐α and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN‐α mRNA in SLE patients. These results suggest that up‐regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN‐α mRNA in PBMCs may also contribute to the pathogenesis of human lupus. Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-α are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription–polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN-α and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN-α and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-α mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-α mRNA in PBMCs may also contribute to the pathogenesis of human lupus. Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-alpha are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription-polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN-alpha and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN-alpha and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-alpha mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-alpha mRNA in PBMCs may also contribute to the pathogenesis of human lupus. Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-α are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription–polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2 , TLR3 , TLR4 , TLR5 , TLR7 , TLR8 , TLR9 , IFN-α and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2 , TLR7 , TLR9, IFN-α and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-α mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-α mRNA in PBMCs may also contribute to the pathogenesis of human lupus. SummaryRecent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)- alpha are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription-polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN- alpha and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN- alpha and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN- alpha mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN- alpha mRNA in PBMCs may also contribute to the pathogenesis of human lupus. |
Author | Komatsuda, A Hatakeyama, T Maki, N Wakui, H Togashi, M Sawada, K Masai, R Ozawa, M Iwamoto, K |
Author_xml | – sequence: 1 fullname: Komatsuda, A – sequence: 2 fullname: Wakui, H – sequence: 3 fullname: Iwamoto, K – sequence: 4 fullname: Ozawa, M – sequence: 5 fullname: Togashi, M – sequence: 6 fullname: Masai, R – sequence: 7 fullname: Maki, N – sequence: 8 fullname: Hatakeyama, T – sequence: 9 fullname: Sawada, K |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20349283$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18373699$$D View this record in MEDLINE/PubMed |
BookMark | eNqNksGO0zAQhi20iO0WXgF8gVuCYydOfABpVS2w0gok2J4tx520Lk4c7IRtX4GnxqGlC6ddX2xr_vk84_kv0FnnOkAIZyTN4nq7TTPGi4TSXKSUkColjOc83T1Bs1PgDM0IISIRGcnP0UUI23jlnNNn6DyrWMm4EDP0a9knHtajVQOsMOx6DyEY12HX4FtnbWLNd8AeNPSD8wG3Xz9fBmw63IM3_Qa8sri2zq1w62KRo7agPNZgbcCNdy3u1WCgGwK-M8MGh30YoDUa27EfAwa_HzbQqsGFMTxHTxtlA7w47nO0_HB1u_iU3Hz5eL24vEl0UVU8KZsyh6rINNGKVlDUIGiuV3VJoSYFVYVghaIrxWrIG1aTjImsoXVVMKVJmRVsjt4fuP1Yt7DSsbrYhey9aZXfS6eM_D_SmY1cu5-S5gWjkTdHb44A736MEAbZmjC1rDpwY5BcZILwkjwozEtelJw_TKQkZ6LMWBS-_Lf2U9F_BxoFr48CFbSyjVedNuGko4TlglYTqDrotHcheGjuUUROHpNbOVlJTlaSk8fkH4_J3f3_nVK1GeKU3fRbxj4G8O4AuDMW9o9-WC6urqdTzH91yG-Uk2rtY3_Lb9NgolgwQjn7DUvR95E |
CODEN | CEXIAL |
CitedBy_id | crossref_primary_10_1016_j_clim_2011_04_016 crossref_primary_10_1371_journal_pone_0107257 crossref_primary_10_3109_09546634_2012_697110 crossref_primary_10_1136_rmdopen_2022_002864 crossref_primary_10_1016_j_bbi_2021_09_009 crossref_primary_10_1155_2012_715190 crossref_primary_10_1155_2016_7697592 crossref_primary_10_1093_infdis_jit262 crossref_primary_10_1038_icb_2011_111 crossref_primary_10_3389_fimmu_2019_01601 crossref_primary_10_3390_jcm9020541 crossref_primary_10_1002_eji_201646641 crossref_primary_10_1073_pnas_1209372109 crossref_primary_10_1172_JCI42213 crossref_primary_10_3390_cells13231946 crossref_primary_10_1101_gr_265249_120 crossref_primary_10_1093_rheumatology_keq001 crossref_primary_10_4049_jimmunol_1202195 crossref_primary_10_33549_physiolres_934167 crossref_primary_10_3109_14397595_2015_1030102 crossref_primary_10_3389_fimmu_2015_00550 crossref_primary_10_1016_j_humimm_2013_08_006 crossref_primary_10_1155_2010_498980 crossref_primary_10_1177_0961203311425522 crossref_primary_10_1007_s11033_010_0590_4 crossref_primary_10_1016_j_humimm_2024_111104 crossref_primary_10_1111_imj_12039 crossref_primary_10_1186_s13075_022_02766_1 crossref_primary_10_1186_s13293_024_00650_y crossref_primary_10_1016_j_clim_2013_10_007 crossref_primary_10_1111_nyas_13534 crossref_primary_10_1371_journal_pgen_1003336 crossref_primary_10_1620_tjem_240_199 crossref_primary_10_1016_j_clim_2016_07_015 crossref_primary_10_1007_s10875_013_9887_0 crossref_primary_10_3389_fphys_2017_00508 crossref_primary_10_1016_j_jid_2016_09_008 crossref_primary_10_1186_ar4193 crossref_primary_10_1007_s00281_014_0445_5 crossref_primary_10_3389_fimmu_2017_01075 crossref_primary_10_3892_etm_2019_7290 crossref_primary_10_1007_s00251_016_0961_7 crossref_primary_10_1172_jci_insight_169584 crossref_primary_10_1177_0961203313511553 crossref_primary_10_1111_j_1365_4632_2009_04111_x crossref_primary_10_1016_j_rdc_2009_03_003 crossref_primary_10_1186_ar3803 crossref_primary_10_1186_s13075_015_0886_9 crossref_primary_10_1507_endocrj_K09E_291 crossref_primary_10_1080_14728222_2020_1832464 crossref_primary_10_1136_rmdopen_2022_002876 crossref_primary_10_1007_s12016_010_8208_0 crossref_primary_10_1038_aps_2015_91 crossref_primary_10_1002_jcb_26155 crossref_primary_10_1016_j_biopha_2017_09_079 crossref_primary_10_3390_v4123701 crossref_primary_10_3892_mmr_2015_3730 crossref_primary_10_1136_ard_2009_124313 crossref_primary_10_1186_s10020_023_00717_3 crossref_primary_10_18705_2782_3806_2022_2_2_63_71 crossref_primary_10_1111_sji_12520 crossref_primary_10_1016_j_clim_2014_01_006 crossref_primary_10_4078_jrd_2018_25_2_81 crossref_primary_10_1016_j_jns_2009_12_018 crossref_primary_10_1007_s11033_014_3447_4 crossref_primary_10_1093_intimm_dxy032 crossref_primary_10_3389_fimmu_2019_01243 crossref_primary_10_1007_s12026_012_8270_1 crossref_primary_10_1080_08820139_2018_1515223 crossref_primary_10_1038_s41584_019_0307_6 crossref_primary_10_1002_art_39867 crossref_primary_10_1371_journal_pone_0260565 crossref_primary_10_2217_epi_2019_0145 crossref_primary_10_1093_rheumatology_ket316 crossref_primary_10_3892_etm_2021_10682 crossref_primary_10_1016_j_micpath_2023_106300 crossref_primary_10_3389_fimmu_2016_00022 crossref_primary_10_1172_JCI120288 crossref_primary_10_3390_ijms22136920 crossref_primary_10_1177_0300985810370005 crossref_primary_10_1111_j_1365_2249_2009_04036_x crossref_primary_10_1371_journal_pone_0120383 crossref_primary_10_1007_s12016_013_8402_y crossref_primary_10_1111_j_1365_2249_2010_04176_x crossref_primary_10_1093_rheumatology_ker400 crossref_primary_10_1186_ar2584 crossref_primary_10_1186_ar3277 crossref_primary_10_3390_ijms20194732 crossref_primary_10_1007_s10067_012_2033_1 crossref_primary_10_1517_14712598_2010_534080 crossref_primary_10_3390_ijms20133234 crossref_primary_10_1016_j_cellimm_2014_12_002 crossref_primary_10_1155_2014_381418 crossref_primary_10_4049_jimmunol_0804318 crossref_primary_10_1016_j_heliyon_2024_e32752 crossref_primary_10_1111_j_1365_3083_2010_02450_x crossref_primary_10_1007_s00393_015_0022_x crossref_primary_10_1111_j_2041_1014_2009_00551_x crossref_primary_10_3389_fimmu_2019_01546 crossref_primary_10_1080_15569543_2018_1469512 crossref_primary_10_1111_ahg_12458 crossref_primary_10_1089_jir_2012_0014 crossref_primary_10_3389_fphar_2014_00265 crossref_primary_10_1186_s40364_022_00436_7 crossref_primary_10_3945_jn_110_135517 crossref_primary_10_4049_jimmunol_1102977 crossref_primary_10_1371_journal_ppat_1005053 crossref_primary_10_1007_s00296_014_3012_4 crossref_primary_10_1016_j_ejmech_2020_112238 crossref_primary_10_1016_j_xcrm_2023_101036 crossref_primary_10_1242_dmm_016451 crossref_primary_10_1002_eji_201445219 crossref_primary_10_1111_cei_13566 crossref_primary_10_2174_1389201023666220114162347 crossref_primary_10_1155_2019_1703842 crossref_primary_10_1186_s12974_021_02215_x crossref_primary_10_1038_s41423_019_0254_9 crossref_primary_10_1042_BJ20090013 crossref_primary_10_1371_journal_pone_0198325 crossref_primary_10_1016_j_immuni_2020_04_004 crossref_primary_10_1007_s10238_011_0161_6 crossref_primary_10_1016_j_bbrc_2010_09_132 crossref_primary_10_1371_journal_pone_0023855 crossref_primary_10_1111_cei_13041 crossref_primary_10_1038_srep03792 crossref_primary_10_1186_s12929_018_0436_2 |
Cites_doi | 10.1084/jem.20050338 10.1002/art.22044 10.1038/nri1957 10.1016/j.smim.2006.12.005 10.1111/j.1365-2796.1990.tb00144.x 10.1084/jem.20050914 10.1136/jcp.56.7.481 10.1016/S0140-6736(07)60279-7 10.4049/jimmunol.177.2.1349 10.1016/j.immuni.2006.07.014 10.1002/art.21553 10.1084/jem.20021553 10.1146/annurev.immunol.21.120601.141152 10.1073/pnas.0337679100 10.1016/j.immuni.2006.07.013 10.1016/j.cell.2006.02.015 10.1016/j.autrev.2006.05.002 10.1002/art.1780400928 10.1038/nri1456 10.1126/science.1105160 10.1080/08916930310001605873 10.1002/art.1780251101 10.1073/pnas.0603912103 10.1002/art.1780350606 10.1002/art.22197 10.1016/j.coi.2006.09.014 |
ContentType | Journal Article |
Copyright | 2008 British Society for Immunology 2008 INIST-CNRS 2008 British Society for Immunology 2008 |
Copyright_xml | – notice: 2008 British Society for Immunology – notice: 2008 INIST-CNRS – notice: 2008 British Society for Immunology 2008 |
DBID | FBQ AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 H94 7S9 L.6 7X8 5PM |
DOI | 10.1111/j.1365-2249.2008.03646.x |
DatabaseName | AGRIS CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef AGRICOLA MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1365-2249 |
EndPage | 487 |
ExternalDocumentID | PMC2453201 18373699 20349283 10_1111_j_1365_2249_2008_03646_x CEI3646 US201300893026 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 169 29B 2WC 31~ 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 5WD 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 A8Z AABZA AACZT AAESR AAEVG AAHHS AAONW AAPXW AARHZ AAUAY AAVAP AAZKR ABCQN ABCUV ABDBF ABDFA ABEJV ABEML ABGNP ABJNI ABLJU ABNHQ ABOCM ABPTD ABPVW ABQNK ABVGC ABXVV ACAHQ ACCFJ ACFBH ACGFO ACGFS ACMXC ACPOU ACPRK ACSCC ACUFI ACUHS ACVCV ACXQS ADBBV ADEOM ADIPN ADIYS ADIZJ ADKYN ADMGS ADOZA ADQBN ADVEK ADXAS ADZMN ADZOD AEEZP AEGXH AEIMD AEMQT AENEX AEQDE AFBPY AFEBI AFFQV AFFZL AFGKR AFRAH AFTUV AFXAL AFZJQ AGMDO AGUTN AHMMS AIACR AIAGR AIURR AIWBW AJAOE AJBDE AJDVS AJEEA AJNCP ALAGY ALMA_UNASSIGNED_HOLDINGS ALXQX AMBMR AMYDB AOIJS ATGXG ATUGU AZBYB AZVAB BAFTC BAWUL BCRHZ BEYMZ BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EAS EBB EBC EBD EBS EBX EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FBQ FUBAC G-S G.N GODZA GX1 H.X H13 HF~ HZI HZ~ IH2 IHE IX1 J0M J5H K48 KBUDW KBYEO KOP KSI KSN LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NOMLY NU- O66 O9- OAUYM OBS OCZFY OHT OIG OJZSN OK1 OPAEJ OVD OWPYF P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 Q~Q R.K ROL ROX RPM RX1 SUPJJ SV3 TEORI TR2 TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOQ WOW WQJ WVDHM WXI X7M XG1 Y6R YFH YOC YUY ZGI ZXP ZZTAW ~IA ~KM ~WT AAFWJ AAMMB AEFGJ AGORE AGXDD AHGBF AIDQK AIDYY AJBYB WIN AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 H94 7S9 L.6 7X8 5PM |
ID | FETCH-LOGICAL-c5886-7f74e851c0ca28e5be924cdb72eb052a5935a2da3be4f3b01391f2b853ac07153 |
IEDL.DBID | DR2 |
ISSN | 0009-9104 1365-2249 |
IngestDate | Thu Aug 21 13:58:46 EDT 2025 Fri Jul 11 05:05:15 EDT 2025 Fri Jul 11 07:57:57 EDT 2025 Fri Jul 11 08:23:20 EDT 2025 Thu Apr 03 06:57:58 EDT 2025 Mon Jul 21 09:15:52 EDT 2025 Tue Jul 01 03:52:22 EDT 2025 Thu Apr 24 23:11:03 EDT 2025 Wed Aug 20 07:27:49 EDT 2025 Thu Apr 03 09:44:55 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Human peripheral blood mononuclear cells Immunopathology Connective tissue disease Skin disease interferon-α Alpha interferon real-time reverse transcription-polymerase chain reaction Autoimmune disease Toll like receptor Biochemistry Biophysics Blood cell Regulation(control) Systemic lupus erythematosus Mononuclear cell Messenger RNA Systemic disease Toll- like receptors Molecular biology Reverse transcription polymerase chain reaction Real time polymerase chain reaction |
Language | English |
License | https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5886-7f74e851c0ca28e5be924cdb72eb052a5935a2da3be4f3b01391f2b853ac07153 |
Notes | http://dx.doi.org/10.1111/j.1365-2249.2008.03646.x ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://doi.org/10.1111/j.1365-2249.2008.03646.x |
PMID | 18373699 |
PQID | 20439713 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2453201 proquest_miscellaneous_69190670 proquest_miscellaneous_47657661 proquest_miscellaneous_20439713 pubmed_primary_18373699 pascalfrancis_primary_20349283 crossref_primary_10_1111_j_1365_2249_2008_03646_x crossref_citationtrail_10_1111_j_1365_2249_2008_03646_x wiley_primary_10_1111_j_1365_2249_2008_03646_x_CEI3646 fao_agris_US201300893026 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | June 2008 |
PublicationDateYYYYMMDD | 2008-06-01 |
PublicationDate_xml | – month: 06 year: 2008 text: June 2008 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England |
PublicationTitle | Clinical and experimental immunology |
PublicationTitleAlternate | Clin Exp Immunol |
PublicationYear | 2008 |
Publisher | Oxford, UK : Blackwell Publishing Ltd Blackwell Publishing Ltd Blackwell Blackwell Science Inc |
Publisher_xml | – name: Oxford, UK : Blackwell Publishing Ltd – name: Blackwell Publishing Ltd – name: Blackwell – name: Blackwell Science Inc |
References | 2007; 19 1982; 25 1997; 40 1990; 227 2007; 369 2000; 27 2006; 54 2005; 202 2006; 25 2004; 4 2003; 36 2005; 307 2006; 5 2006; 18 2006; 6 1992; 35 2007; 34 2003; 100 2003; 21 2006; 177 2006; 103 2003; 197 2003; 56 2006; 124 Pascual (2022010405183746300_b7) 2006; 18 Subramanian (2022010405183746300_b23) 2006; 103 Mackay (2022010405183746300_b3) 2003; 21 Papadimitraki (2022010405183746300_b11) 2006; 54 Baechler (2022010405183746300_b26) 2003; 100 Barrat (2022010405183746300_b28) 2005; 202 D'Cruz (2022010405183746300_b2) 2007; 369 Hochberg (2022010405183746300_b15) 1997; 40 Wu (2022010405183746300_b19) 2006; 54 Feng (2022010405183746300_b13) 2006; 54 Christensen (2022010405183746300_b9) 2007; 19 Lartigue (2022010405183746300_b20) 2006; 177 Cook (2022010405183746300_b17) 2000; 27 Mok (2022010405183746300_b1) 2003; 56 Akira (2022010405183746300_b10) 2006; 124 Tan (2022010405183746300_b14) 1982; 25 Migita (2022010405183746300_b12) 2007; 34 Bennett (2022010405183746300_b27) 2003; 197 McGaha (2022010405183746300_b5) 2005; 307 Christensen (2022010405183746300_b18) 2005; 202 Christensen (2022010405183746300_b22) 2006; 25 Carroll (2022010405183746300_b4) 2004; 4 Bombardier (2022010405183746300_b16) 1992; 35 Koutouzov (2022010405183746300_b6) 2006; 5 Marshak-Rothstein (2022010405183746300_b8) 2006; 6 Berland (2022010405183746300_b21) 2006; 25 Gota (2022010405183746300_b25) 2003; 36 Rönnblom (2022010405183746300_b24) 1990; 227 17307106 - Lancet. 2007 Feb 17;369(9561):587-96 17276080 - Semin Immunol. 2007 Feb;19(1):11-23 16497588 - Cell. 2006 Feb 24;124(4):783-801 9324032 - Arthritis Rheum. 1997 Sep;40(9):1725 16027240 - J Exp Med. 2005 Jul 18;202(2):321-31 15681388 - Science. 2005 Jan 28;307(5709):590-3 12642603 - J Exp Med. 2003 Mar 17;197(6):711-23 17027892 - Autoimmun Rev. 2006 Oct;5(8):554-62 16385525 - Arthritis Rheum. 2006 Jan;54(1):336-42 16947629 - Arthritis Rheum. 2006 Sep;54(9):2951-62 16973389 - Immunity. 2006 Sep;25(3):417-28 17075805 - Arthritis Rheum. 2006 Nov;54(11):3601-11 16973388 - Immunity. 2006 Sep;25(3):429-40 17011763 - Curr Opin Immunol. 2006 Dec;18(6):676-82 16230478 - J Exp Med. 2005 Oct 17;202(8):1131-9 14984028 - Autoimmunity. 2003 Dec;36(8):511-8 12604793 - Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2610-5 1599520 - Arthritis Rheum. 1992 Jun;35(6):630-40 17295441 - J Rheumatol. 2007 Mar;34(3):493-500 12835292 - J Clin Pathol. 2003 Jul;56(7):481-90 15459673 - Nat Rev Immunol. 2004 Oct;4(10):825-31 17063184 - Nat Rev Immunol. 2006 Nov;6(11):823-35 16777955 - Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9970-5 10955329 - J Rheumatol. 2000 Aug;27(8):1892-5 12427767 - Annu Rev Immunol. 2003;21:231-64 16818796 - J Immunol. 2006 Jul 15;177(2):1349-54 1690258 - J Intern Med. 1990 Mar;227(3):207-10 7138600 - Arthritis Rheum. 1982 Nov;25(11):1271-7 |
References_xml | – volume: 25 start-page: 1271 year: 1982 end-page: 7 article-title: The 1982 revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum – volume: 25 start-page: 417 year: 2006 end-page: 28 article-title: Toll‐like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus publication-title: Immunity – volume: 4 start-page: 825 year: 2004 end-page: 31 article-title: A protective role for innate immunity in systemic lupus erythematosus publication-title: Nat Rev Immunol – volume: 307 start-page: 590 year: 2005 end-page: 3 article-title: Restoration of tolerance in lupus by targeted inhibitory receptor expression publication-title: Science – volume: 369 start-page: 587 year: 2007 end-page: 96 article-title: Systemic lupus erythematosus publication-title: Lancet – volume: 103 start-page: 9970 year: 2006 end-page: 5 article-title: A translocation accelerates systemic autoimmunity in murine lupus publication-title: Proc Natl Acad Sci USA – volume: 54 start-page: 2951 year: 2006 end-page: 62 article-title: Association of increased interferon‐inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus publication-title: Arthritis Rheum – volume: 202 start-page: 321 year: 2005 end-page: 31 article-title: Toll‐like receptor 9 controls anti‐DNA autoantibody production in murine lupus publication-title: J Exp Med – volume: 40 start-page: 1725 year: 1997 article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum – volume: 100 start-page: 2610 year: 2003 end-page: 15 article-title: Interferon‐inducible gene expression signature in peripheral blood cells of patients with severe lupus publication-title: Proc Natl Acad Sci USA – volume: 25 start-page: 429 year: 2006 end-page: 40 article-title: Toll‐like receptor 7‐dependent loss of B cell tolerance in pathogenic autoantibody knockin mice publication-title: Immunity – volume: 36 start-page: 511 year: 2003 end-page: 18 article-title: Induction of clinical autoimmune disease by therapeutic interferon‐alpha publication-title: Autoimmunity – volume: 21 start-page: 231 year: 2003 end-page: 64 article-title: BAFF and APRIL: a tutorial on B cell survival publication-title: Annu Rev Immunol – volume: 124 start-page: 783 year: 2006 end-page: 801 article-title: Pathogen reaction and innate immunity publication-title: Cell – volume: 27 start-page: 1892 year: 2000 end-page: 5 article-title: Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity publication-title: J Rheumatol – volume: 35 start-page: 630 year: 1992 end-page: 40 article-title: Derivation of the SLEDAI: a disease activity index for lupus patients publication-title: Arthritis Rheum – volume: 6 start-page: 823 year: 2006 end-page: 35 article-title: Toll‐like receptors in systemic autoimmune disease publication-title: Nat Rev Immunol – volume: 19 start-page: 11 year: 2007 end-page: 23 article-title: Regulation of lupus‐related autoantibody production and clinical disease by Toll‐like receptors publication-title: Semin Immunol – volume: 54 start-page: 3601 year: 2006 end-page: 11 article-title: Expansion of toll‐like receptor 9‐expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process publication-title: Arthritis Rheum – volume: 197 start-page: 711 year: 2003 end-page: 23 article-title: Interferon and granulopoiesis signatures in systemic lupus erythematosus blood publication-title: J Exp Med – volume: 34 start-page: 493 year: 2007 end-page: 500 article-title: Toll‐like receptor expression in lupus peripheral blood mononuclear cells publication-title: J Rheumatol – volume: 5 start-page: 554 year: 2006 end-page: 62 article-title: Type‐I interferons and systemic lupus erythematosus publication-title: Autoimmun Rev – volume: 227 start-page: 207 year: 1990 end-page: 10 article-title: Possible induction of systemic lupus erythematosus by interferon‐alpha treatment in a patient with a malignant carcinoid tumour publication-title: J Intern Med – volume: 202 start-page: 1131 year: 2005 end-page: 9 article-title: Nucleic acids of mammalian origin can act as endogenous ligands for Toll‐like receptors and may promote systemic lupus erythematosus publication-title: J Exp Med – volume: 56 start-page: 481 year: 2003 end-page: 90 article-title: Pathogenesis of systemic lupus erythematosus publication-title: J Clin Pathol – volume: 18 start-page: 676 year: 2006 end-page: 82 article-title: Systemic lupus erythematosus: all roads lead to type I interferons publication-title: Curr Opin Immunol – volume: 54 start-page: 336 year: 2006 end-page: 42 article-title: Toll‐like receptor 9 signaling protects against murine lupus publication-title: Arthritis Rheum – volume: 177 start-page: 1349 year: 2006 end-page: 54 article-title: Role of TLR9 in anti‐nucleosome and anti‐DNA antibody production in mutation‐induced murine lupus publication-title: J Immunol – volume: 202 start-page: 321 year: 2005 ident: 2022010405183746300_b18 article-title: Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus publication-title: J Exp Med doi: 10.1084/jem.20050338 – volume: 54 start-page: 2951 year: 2006 ident: 2022010405183746300_b13 article-title: Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.22044 – volume: 6 start-page: 823 year: 2006 ident: 2022010405183746300_b8 article-title: Toll-like receptors in systemic autoimmune disease publication-title: Nat Rev Immunol doi: 10.1038/nri1957 – volume: 19 start-page: 11 year: 2007 ident: 2022010405183746300_b9 article-title: Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors publication-title: Semin Immunol doi: 10.1016/j.smim.2006.12.005 – volume: 27 start-page: 1892 year: 2000 ident: 2022010405183746300_b17 article-title: Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity publication-title: J Rheumatol – volume: 227 start-page: 207 year: 1990 ident: 2022010405183746300_b24 article-title: Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour publication-title: J Intern Med doi: 10.1111/j.1365-2796.1990.tb00144.x – volume: 202 start-page: 1131 year: 2005 ident: 2022010405183746300_b28 article-title: Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus publication-title: J Exp Med doi: 10.1084/jem.20050914 – volume: 56 start-page: 481 year: 2003 ident: 2022010405183746300_b1 article-title: Pathogenesis of systemic lupus erythematosus publication-title: J Clin Pathol doi: 10.1136/jcp.56.7.481 – volume: 369 start-page: 587 year: 2007 ident: 2022010405183746300_b2 article-title: Systemic lupus erythematosus publication-title: Lancet doi: 10.1016/S0140-6736(07)60279-7 – volume: 177 start-page: 1349 year: 2006 ident: 2022010405183746300_b20 article-title: Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus publication-title: J Immunol doi: 10.4049/jimmunol.177.2.1349 – volume: 25 start-page: 429 year: 2006 ident: 2022010405183746300_b21 article-title: Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice publication-title: Immunity doi: 10.1016/j.immuni.2006.07.014 – volume: 34 start-page: 493 year: 2007 ident: 2022010405183746300_b12 article-title: Toll-like receptor expression in lupus peripheral blood mononuclear cells publication-title: J Rheumatol – volume: 54 start-page: 336 year: 2006 ident: 2022010405183746300_b19 article-title: Toll-like receptor 9 signaling protects against murine lupus publication-title: Arthritis Rheum doi: 10.1002/art.21553 – volume: 197 start-page: 711 year: 2003 ident: 2022010405183746300_b27 article-title: Interferon and granulopoiesis signatures in systemic lupus erythematosus blood publication-title: J Exp Med doi: 10.1084/jem.20021553 – volume: 21 start-page: 231 year: 2003 ident: 2022010405183746300_b3 article-title: BAFF and APRIL: a tutorial on B cell survival publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.21.120601.141152 – volume: 100 start-page: 2610 year: 2003 ident: 2022010405183746300_b26 article-title: Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0337679100 – volume: 25 start-page: 417 year: 2006 ident: 2022010405183746300_b22 article-title: Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus publication-title: Immunity doi: 10.1016/j.immuni.2006.07.013 – volume: 124 start-page: 783 year: 2006 ident: 2022010405183746300_b10 article-title: Pathogen reaction and innate immunity publication-title: Cell doi: 10.1016/j.cell.2006.02.015 – volume: 5 start-page: 554 year: 2006 ident: 2022010405183746300_b6 article-title: Type-I interferons and systemic lupus erythematosus publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2006.05.002 – volume: 40 start-page: 1725 year: 1997 ident: 2022010405183746300_b15 article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.1780400928 – volume: 4 start-page: 825 year: 2004 ident: 2022010405183746300_b4 article-title: A protective role for innate immunity in systemic lupus erythematosus publication-title: Nat Rev Immunol doi: 10.1038/nri1456 – volume: 307 start-page: 590 year: 2005 ident: 2022010405183746300_b5 article-title: Restoration of tolerance in lupus by targeted inhibitory receptor expression publication-title: Science doi: 10.1126/science.1105160 – volume: 36 start-page: 511 year: 2003 ident: 2022010405183746300_b25 article-title: Induction of clinical autoimmune disease by therapeutic interferon-alpha publication-title: Autoimmunity doi: 10.1080/08916930310001605873 – volume: 25 start-page: 1271 year: 1982 ident: 2022010405183746300_b14 article-title: The 1982 revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.1780251101 – volume: 103 start-page: 9970 year: 2006 ident: 2022010405183746300_b23 article-title: A Tlr7 translocation accelerates systemic autoimmunity in murine lupus publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0603912103 – volume: 35 start-page: 630 year: 1992 ident: 2022010405183746300_b16 article-title: Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE publication-title: Arthritis Rheum doi: 10.1002/art.1780350606 – volume: 54 start-page: 3601 year: 2006 ident: 2022010405183746300_b11 article-title: Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process publication-title: Arthritis Rheum doi: 10.1002/art.22197 – volume: 18 start-page: 676 year: 2006 ident: 2022010405183746300_b7 article-title: Systemic lupus erythematosus: all roads lead to type I interferons publication-title: Curr Opin Immunol doi: 10.1016/j.coi.2006.09.014 – reference: 16947629 - Arthritis Rheum. 2006 Sep;54(9):2951-62 – reference: 16973388 - Immunity. 2006 Sep;25(3):429-40 – reference: 16027240 - J Exp Med. 2005 Jul 18;202(2):321-31 – reference: 12835292 - J Clin Pathol. 2003 Jul;56(7):481-90 – reference: 16497588 - Cell. 2006 Feb 24;124(4):783-801 – reference: 10955329 - J Rheumatol. 2000 Aug;27(8):1892-5 – reference: 16385525 - Arthritis Rheum. 2006 Jan;54(1):336-42 – reference: 17295441 - J Rheumatol. 2007 Mar;34(3):493-500 – reference: 7138600 - Arthritis Rheum. 1982 Nov;25(11):1271-7 – reference: 1599520 - Arthritis Rheum. 1992 Jun;35(6):630-40 – reference: 12604793 - Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2610-5 – reference: 16230478 - J Exp Med. 2005 Oct 17;202(8):1131-9 – reference: 17075805 - Arthritis Rheum. 2006 Nov;54(11):3601-11 – reference: 15681388 - Science. 2005 Jan 28;307(5709):590-3 – reference: 16777955 - Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9970-5 – reference: 12642603 - J Exp Med. 2003 Mar 17;197(6):711-23 – reference: 12427767 - Annu Rev Immunol. 2003;21:231-64 – reference: 16818796 - J Immunol. 2006 Jul 15;177(2):1349-54 – reference: 17011763 - Curr Opin Immunol. 2006 Dec;18(6):676-82 – reference: 17276080 - Semin Immunol. 2007 Feb;19(1):11-23 – reference: 17027892 - Autoimmun Rev. 2006 Oct;5(8):554-62 – reference: 1690258 - J Intern Med. 1990 Mar;227(3):207-10 – reference: 17307106 - Lancet. 2007 Feb 17;369(9561):587-96 – reference: 9324032 - Arthritis Rheum. 1997 Sep;40(9):1725 – reference: 17063184 - Nat Rev Immunol. 2006 Nov;6(11):823-35 – reference: 15459673 - Nat Rev Immunol. 2004 Oct;4(10):825-31 – reference: 14984028 - Autoimmunity. 2003 Dec;36(8):511-8 – reference: 16973389 - Immunity. 2006 Sep;25(3):417-28 |
SSID | ssj0006662 |
Score | 2.2982464 |
Snippet | Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-α are... Summary Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll‐like receptors (TLR‐7 and TLR‐9) and interferon (IFN)‐α are... Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-alpha are... SummaryRecent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)- alpha... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref wiley fao |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 482 |
SubjectTerms | Adolescent Adult Aged Analytical, structural and metabolic biochemistry Antigens, Surface - biosynthesis Antigens, Surface - genetics Biological and medical sciences Female Fundamental and applied biological sciences. Psychology GPI-Linked Proteins Humans Interferon-alpha - biosynthesis Interferon-alpha - genetics interferon-α Leukocytes, Mononuclear - immunology Lupus Erythematosus, Systemic - immunology Male Medical sciences Membrane Proteins - biosynthesis Membrane Proteins - genetics Middle Aged Molecular biophysics mononuclear leukocytes peripheral blood mononuclear cells real-time reverse transcription-polymerase chain reaction Reverse Transcriptase Polymerase Chain Reaction - methods RNA, Messenger - genetics Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis systemic lupus erythematosus Toll-like receptors Toll-Like Receptors - biosynthesis Toll-Like Receptors - genetics Translational Studies Up-Regulation - immunology |
Title | Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2249.2008.03646.x https://www.ncbi.nlm.nih.gov/pubmed/18373699 https://www.proquest.com/docview/20439713 https://www.proquest.com/docview/47657661 https://www.proquest.com/docview/69190670 https://pubmed.ncbi.nlm.nih.gov/PMC2453201 |
Volume | 152 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLZgCMQLl3FZuRQ_8JoqcWwnfuzGqoG0PYxV2ltkp_aoWpKqaaSNJ34B4jfySzgnTrsFBpoQb5VsJ83R8Tmf7c_fIeQt5BTFU6cDoYwIOOp9qogngbahynWkReTwRPfwSB6M-YdTcdryn_AujNeH2Gy44cxo4jVOcG2q7iRvGFqwfmgpkbHkcoB4EhsQHx1fKkkBSmfromqQIXmX1HPtgzqZ6rbTJfImdQWmc77mxXWg9Hdu5VXM2ySt0UMyW3-u56rMBvXKDPIvvyhB_h97PCIPWmxLh94ZH5Nbttgmd321y4ttcu-wPcd_Qr6NFz--fl_aMyweZifUnrd83IKWjp6Ab0LzfDqzFAKyXWBFIPr5-GhY0WlBUZu5EUOY04Z2T2EmlQXqMuslxYOIiuKlGdpKxlYU95qpl6ye5nReL-qK2uWF16stq7p6Ssaj_ZO9g6CtDBHkIk1lkLiEW8CKeZhrllphLCwj84lJmDWhYFqoWGg20bGx3MW41asixwxAE50DphLxM7IF_8zuEMoAYMnIxFaCj0JKN85MrFMsglFhaNMeSdZekOWtbDpW75hnV5ZPYPgMDd8W9UTDZ-c9Em1GLrx0yA3G7ICjZfoMInw2_sjwXDkESAkr5R7pd7xv80yGEkOAEnvkzdodM4gRaG9d2LKusub-cxL9pQdPJCw8ZfTnHmAehXe6euS5d_DLb0rjJJZKgaU6rr_pgArm3ZZi-qlRMmcc65LAW2Xj2Tc2U7a3_x5_vfjXgS_JfU_8we20V2Rrtazta0CXK9Mnd4a773ZH_SZ-_ATSwG85 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagiMeFR3l0ebQ-cM0qcWwnPlal1Ra6eyi7Um-WnXXKqiFZbTZSy4lfgPiN_BJmkuy2gYIqxC1S7DxG4_Hn8fj7CHkLc4ricWo8oazwOPJ9qoBHnnG-SkxgRJDiju5wJAcT_v5EnLRyQHgWpuGHWCfccGTU8RoHOCaku6O8LtGCBURbExlKLvsAKO-gwDcS6b87vuSSApzOVrJqMEfyblnPtU_qzFW3U1Ng5aQpwXhpo3pxHSz9vbryKuqtp62DRyRb_XBTrXLWr5a2n3z5hQvyP1nkMXnYwlu62_jjE3LL5ZvkbiN4ebFJ7g3brfyn5Ntk_uPr94U7Rf0wN6XuvC3JzWmR0jG4J9zOZmeOQkx2cxQFop-PR7slneUU6ZlrPoSM1pX3FAZTkSM1s1lQ3IsoKZ6boS1rbEkx3Uwb1upZQrNqXpXULS4aytqirMpnZHKwP94beK04hJeIOJZelEbcAVxM_MSw2AnrYCWZTG3EnPUFM0KFwrCpCa3jaYjZXhWkzAI6MQnAKhE-JxvwZW6LUAYYSwY2dBLcFGZ1m9qpSxULoJfvu7hHopUb6KRlTkcBj0xfWUGB4TUavtX1RMPr8x4J1j3nDXvIDfpsgadpcwpBXk8-Mtxa9gFVwmK5R7Y77rd-JkOWIQCKPbKz8kcNYQLtbXJXVKWuj0BHwV9a8EjC2lMGf24B5lF4rKtHXjQefvlPcRiFUimwVMf31w2QxLx7J599qsnMGUdpEnirrF37xmbSe_uHePXyXzvukPuD8fBIHx2OPrwiD5o6IMyuvSYby0Xl3gDYXNrtOoj8BA8-ceM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagiIoLj_JoeLQ-cM0qcRwnPlZtVy3QFSpdqbfITux2tUsSbTZSy4lfgPiN_BJmkuy2gYIqxC1S7DxGn2c-2-NvCHkLMUXy2Co3lDp0Oep9Sp9HrjKeTJWvQt_iju7RSByM-bvT8LTLf8KzMK0-xGrBDUdG469xgJeZ7Q_yJkML5g9dSmQguBgAn7zHhSexjMPe8ZWUFNB0tqyqBiGS97N6bnxSL1TdtarAxElVge1sW_TiJlb6e3LlddLbRK3hIzJd_m-brDId1As9SL_8IgX5fwzymDzsyC3dadH4hNwx-Qa535a7vNwg60fdRv5T8m1c_vj6fW7OsHqYyai56BJyc1pYegLghNuzydRQ8MimxJJA9PPxaKeik5yiOHOjhjCjTd49haFU5CjMrOYUdyIqiqdmaKcZW1FcbKatZvUkpbO6rCtq5petYG1R1dUzMh7un-weuF1pCDcN41i4kY24AbKYeqlisQm1gXlkmumIGe2FTIUyCBXLVKANtwGu9UrfMg3cRKVAqsLgOVmDLzObhDJgWMLXgREAUojp2urMWMl86OV5JnZItERBkna66Vi-Y5Zcmz-B4RM0fFfVEw2fXDjEX_UsW-2QW_TZBKAl6gxcfDL-xHBj2QNOCVNlh2z10Ld6JkONIaCJDtlewjEBJ4H2Vrkp6ippDkBH_l9a8EjAzFP4f24B5pF4qMshL1qAX_1THESBkBIs1YP-qgFKmPfv5JPzRsqccSxMAm8VDbJvbaZkd_8Qr17-a8dtsv5xb5h8OBy9f0UetElAuLT2mqwt5rV5A0xzobcaF_ITVXZwkg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Up-regulated+expression+of+Toll-like+receptors+mRNAs+in+peripheral+blood+mononuclear+cells+from+patients+with+systemic+lupus+erythematosus&rft.jtitle=Clinical+and+experimental+immunology&rft.au=Komatsuda%2C+A&rft.au=Wakui%2C+H&rft.au=Iwamoto%2C+K&rft.au=Ozawa%2C+M&rft.date=2008-06-01&rft.issn=0009-9104&rft.eissn=1365-2249&rft.volume=152&rft.issue=3&rft.spage=482&rft.epage=487&rft_id=info:doi/10.1111%2Fj.1365-2249.2008.03646.x&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-9104&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-9104&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-9104&client=summon |